Biologic Therapies for Asthma and Allergic Disease: Past, Present, and Future

Biologic Therapies for Asthma and Allergic Disease: Past, Present, and Future

The discovery of the mechanism underlying allergic disease, mouse models of asthma, and bronchoscopy studies provided initial insights into the role of Th2-type cytokines, including interlukin (IL)-4, IL-5 and IL-13, which became the target of monoclonal antibody therapy. Omalizumab, Benralizumab, M...

Full description

Bibliographic Details
Main Authors: Fernando Ramírez-Jiménez, Gandhi Fernando Pavón-Romero, Juancarlos Manuel Velásquez-Rodríguez, Mariana Itzel López-Garza, José Fernando Lazarini-Ruiz, Katia Vanessa Gutiérrez-Quiroz, Luis M. Teran
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Pharmaceuticals
Subjects:
asthma
biologic therapies
monoclonal antibodies
cytokines
chemokines
Online Access:https://www.mdpi.com/1424-8247/16/2/270

Internet

https://www.mdpi.com/1424-8247/16/2/270

Similar Items